ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2025
COVID-19 evolution in pediatric emergency department patients in Madrid, Spain: a single-center, retrospective study.
Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionCOVID-19, caused by the SARS-CoV-2 virus, had a significant global impact since its emergence in December 2019. In Spain, the pandemic caused multiple waves of infections, with variations in clinical presentation and predominant viral strains. This study analyzed the evolution of COVID-19 in pediatric patients in a pediatric emergency department in Madrid (Spain), focusing on the changes in clinical manifestations over time.
methodsThis single-center, retrospective study was conducted from March 2020 to October 2024, including pediatric patients aged 0-18 years with confirmed SARS-CoV-2 infection. Data collected included demographic characteristics, clinical manifestations, and hospital admission rates. The sample was divided into groups based on the predominant circulating variant during specific periods.
resultsA total of 1,949 confirmed COVID-19 cases were analyzed. The median age of the patients was 1.2 years (IQR: 0.4-7.4). The highest number of recorded cases was in infants aged 1-12 months (43.4%). Fever (77.6%) and respiratory symptoms (68.8%) were the most common clinical manifestations. A statistically significant association was observed between the presence of fever and the XBB variant (p < 0.015), the presence of upper respiratory symptoms and the XBB variant (p = 0.015), the presence of gastrointestinal symptoms and the Omicron BA.2 variant (p = 0.009), and the presence of laryngitis and the XBB variant (p < 0.001). The highest number of admissions was recorded in patients aged 1-12 months (61/133; 45.9%), followed by school-aged children aged 6-11 years (22/133; 16.5%).
conclusionThe clinical presentation and age distribution of COVID-19 infections have changed over time. Infants aged 1-12 months were the most affected, a consistent trend across the pandemic. Fever remained the most common clinical manifestation throughout the study period, followed by upper respiratory symptoms.
Indexed as
Identifiers
40202599What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.